Basics Monte Rosa Therapeutics, Inc. IPO Date: June 24, 2021 Sector: Healthcare Industry: Biotech Market Cap: $321.7M Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 4.21% Avg Daily Range (30 D): $0.12 | 2.34% Avg Daily Range (90 D): $0.17 | 3.47% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .37M Avg Daily Volume (90 D): .52M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 76 Avg Trade Size (Sh.) (90 D): 91 Institutional Trades Total Inst.Trades: 224 Avg Inst. Trade: $2.77M Avg Inst. Trade (30 D): $1.18M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .3M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.86M Avg Closing Trade (30 D): $1.4M Avg Closing Trade (90 D): $1.31M Avg Closing Volume: 252.52K     News Jul 21, 2025 @ 11:00 AM Monte Rosa Therapeutics Announces First Subjects D... Source: Monte Rosa Therapeutics Jul 3, 2025 @ 6:15 PM Monte Rosa Announces Publication in Science of Key... Source: Monte Rosa Therapeutics Jun 10, 2025 @ 11:00 AM Monte Rosa Therapeutics Announces FDA Clearance of... Source: N/A Apr 28, 2025 @ 11:00 AM Monte Rosa Therapeutics Presents Preclinical Data ... Source: N/A Jan 6, 2025 @ 12:00 PM Monte Rosa Therapeutics to Present at the 43rd Ann... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS Diluted EPS Revenue $ 159.49M $ 84.93M $ 60.65M Gross Profit $ $ $ Net Income / Loss $ 6.15M $ 46.89M $ 13.44M Operating Income / Loss $ -2.13M $ 44.04M $ 13M Cost of Revenue $ $ $ Net Cash Flow $ -21.21M $ -145.71M $ 98.63M PE Ratio